Novartis Ag (NVS) Change in Acquisitions & Divestments (2009 - 2026)

Novartis Ag (NVS) has 11 years of Change in Acquisitions & Divestments data on file, last reported at -$3.0 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments changed 0.0% year-over-year to -$3.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $114.0 million (up 293.1% YoY) and the FY2025 annual result came in at -$24.0 million, down 242.86% from the prior year.
• Change in Acquisitions & Divestments fell to -$3.0 million in Q1 2026 per NVS's latest filing, from $48.0 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $2.1 billion in Q2 2022, with the low at -$958.0 million in Q3 2024.
• Average Change in Acquisitions & Divestments over 5 years is $186.3 million, with a median of $39.0 million recorded in 2025.
• The widest YoY moves for Change in Acquisitions & Divestments: up 14233.33% in 2024, down 581.41% in 2024.
• Novartis Ag's Change in Acquisitions & Divestments stood at $12.0 million in 2022, then soared by 166.67% to $32.0 million in 2023, then soared by 1650.0% to $560.0 million in 2024, then tumbled by 91.43% to $48.0 million in 2025, then tumbled by 106.25% to -$3.0 million in 2026.
• Business Quant data shows NVS's Change in Acquisitions & Divestments at -$3.0 million in Q1 2026, $48.0 million in Q4 2025, and $39.0 million in Q3 2025.